CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Market player positioning, 2018
3.3. Porter's five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in demand for noninvasive and safer surgical treatments
3.4.1.2. Increase in number of patients demanding bone growth stimulators
3.4.1.3. Increase in government expenditure on healthcare
3.4.2. Restraint
3.4.2.1. Stringent approval process of bone growth stimulators
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.4. Impact analysis
CHAPTER 4: BONE GROWTH STIMULATORS TREATMENT MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Bone growth stimulation devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Bone Morphogenetic Proteins
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Platelet-rich plasma
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: BONE GROWTH STIMULATORS TREATMENT MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Spinal Fusion Surgeries
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Delayed Union & Nonunion Bone Fractures
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Oral & Maxillofacial Surgeries
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: BONE GROWTH STIMULATORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Home Care
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: BONE GROWTH STIMULATORS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. bone growth stimulators market, by product
7.2.2.1.2. U.S. bone growth stimulators market, by application
7.2.2.1.3. U.S. bone growth stimulators market, by distribution channel
7.2.2.2. Canada
7.2.2.2.1. Canada bone growth stimulators market, by product
7.2.2.2.2. Canada bone growth stimulators market, by application
7.2.2.2.3. Canada bone growth stimulators market, by distribution channel
7.2.2.3. Mexico
7.2.2.3.1. Mexico bone growth stimulators market, by product
7.2.2.3.2. Mexico bone growth stimulators market, by application
7.2.2.3.3. Mexico bone growth stimulators market, by distribution channel
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by distribution channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany bone growth stimulators market, by product
7.3.2.1.2. Germany bone growth stimulators market, by application
7.3.2.1.3. Germany bone growth stimulators market, by distribution channel
7.3.2.2. France
7.3.2.2.1. France bone growth stimulators market, by product
7.3.2.2.2. France bone growth stimulators market, by application
7.3.2.2.3. France bone growth stimulators market, by distribution channel
7.3.2.3. UK
7.3.2.3.1. UK bone growth stimulators market, by product
7.3.2.3.2. UK bone growth stimulators market, by application
7.3.2.3.3. UK bone growth stimulators market, by distribution channel
7.3.2.4. Italy
7.3.2.4.1. Italy bone growth stimulators market, by product
7.3.2.4.2. Italy bone growth stimulators market, by application
7.3.2.4.3. Italy bone growth stimulators market, by distribution channel
7.3.2.5. Spain
7.3.2.5.1. Spain bone growth stimulators market, by product
7.3.2.5.2. Spain bone growth stimulators market, by application
7.3.2.5.3. Spain bone growth stimulators market, by distribution channel
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe bone growth stimulators market, by product
7.3.2.6.2. Rest of Europe bone growth stimulators market, by application
7.3.2.6.3. Rest of Europe bone growth stimulators market, by distribution channel
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by distribution channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan bone growth stimulators market, by product
7.4.2.1.2. Japan bone growth stimulators market, by application
7.4.2.1.3. Japan bone growth stimulators market, by distribution channel
7.4.2.2. China
7.4.2.2.1. China bone growth stimulators market, by product
7.4.2.2.2. China bone growth stimulators market, by application
7.4.2.2.3. China bone growth stimulators market, by distribution channel
7.4.2.3. Australia
7.4.2.3.1. Australia bone growth stimulators market, by product
7.4.2.3.2. Australia bone growth stimulators market, by application
7.4.2.3.3. Australia bone growth stimulators market, by distribution channel
7.4.2.4. India
7.4.2.4.1. India bone growth stimulators market, by product
7.4.2.4.2. India bone growth stimulators market, by application
7.4.2.4.3. India bone growth stimulators market, by distribution channel
7.4.2.5. South Korea
7.4.2.5.1. South Korea bone growth stimulators market, by product
7.4.2.5.2. South Korea bone growth stimulators market, by application
7.4.2.5.3. South Korea bone growth stimulators market, by distribution channel
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific bone growth stimulators market, by product
7.4.2.6.2. Rest of Asia-Pacific bone growth stimulators market, by application
7.4.2.6.3. Rest of Asia-Pacific bone growth stimulators market, by distribution channel
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by distribution channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil bone growth stimulators market, by product
7.5.2.1.2. Brazil bone growth stimulators market, by application
7.5.2.1.3. Brazil bone growth stimulators market, by distribution channel
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia bone growth stimulators market, by product
7.5.2.2.2. Saudi Arabia bone growth stimulators market, by application
7.5.2.2.3. Saudi Arabia bone growth stimulators market, by distribution channel
7.5.2.3. South Africa
7.5.2.3.1. South Africa bone growth stimulators market, by product
7.5.2.3.2. South Africa bone growth stimulators market, by application
7.5.2.3.3. South Africa bone growth stimulators market, by distribution channel
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA bone growth stimulators market, by product
7.5.2.4.2. Rest of LAMEA bone growth stimulators market, by application
7.5.2.4.3. Rest of LAMEA bone growth stimulators market, by distribution channel
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by distribution channel
CHAPTER 8: COMPANY PROFILES
8.1. Arthrex, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.2. Essex Woodlands Healthcare Partners (Bioventus LLC)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.1. Key strategic moves and developments
8.3. Colfax Corporation (DJO Global, Inc)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Isto Biologics
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. JOHNSON & JOHNSON (DEPUY SYNTHES)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Orthofix Medical Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. STRYKER CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Terumo Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. ZIMMER BIOMET HOLDINGS, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance